PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $958,608 | -80.1% | 151,200 | -59.9% | 0.00% | -100.0% |
Q4 2023 | $4,805,475 | -2.8% | 376,900 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $4,946,403 | +95.7% | 377,300 | +66.9% | 0.00% | 0.0% |
Q1 2023 | $2,527,798 | -19.8% | 226,100 | -39.6% | 0.00% | 0.0% |
Q4 2022 | $3,153,663 | -16.3% | 374,100 | +65.5% | 0.00% | 0.0% |
Q3 2022 | $3,766,826 | +9.8% | 226,100 | -3.0% | 0.00% | 0.0% |
Q2 2022 | $3,431,232 | +161.7% | 233,100 | +470.2% | 0.00% | – |
Q4 2021 | $1,311,000 | -10.9% | 40,880 | 0.0% | 0.00% | – |
Q3 2021 | $1,471,000 | +15.7% | 40,880 | +41.9% | 0.00% | – |
Q2 2021 | $1,271,000 | – | 28,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
Yu Fan | 303,030 | $13,861,000 | 36.18% |
ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
Miura Global Management | 405,000 | $18,525,000 | 3.31% |
GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |